Corvus Pharmaceuticals, Inc. financial statements
Corvus Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 15.28M | 10-K |
| Cash and equivalents | USD 4.58M | 10-Q |
| Total debt | USD 937K | EODHD |
Corvus Pharmaceuticals, Inc. financials on 6ix · Corvus Pharmaceuticals, Inc. on 6ix